The ubiquitin-like molecule interferon-stimulated gene 15 is overexpressed in human prostate cancer.
暂无分享,去创建一个
Kenji Tamura | K. Tamura | T. Shuin | M. Furihata | S. Ashida | Mutsuo Furihata | Taro Shuin | Shingo Ashida | Hirofumi Satake | Takashi Anchi | Hatsune Sakoda | Chiaki Kawada | Tatsuo Iiyama | T. Iiyama | Hirofumi Satake | C. Kawada | T. Anchi | H. Sakoda
[1] M. Hochstrasser,et al. Evolution and function of ubiquitin-like protein-conjugation systems , 2000, Nature Cell Biology.
[2] B. Korant,et al. Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. , 1984, The Journal of biological chemistry.
[3] G. Stark. How cells respond to interferons revisited: from early history to current complexity. , 2007, Cytokine & growth factor reviews.
[4] H. Scher,et al. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] D. Feldman,et al. The development of androgen-independent prostate cancer , 2001, Nature Reviews Cancer.
[6] S. Devesa,et al. Trends and patterns of prostate cancer: what do they suggest? , 2001, Epidemiologic reviews.
[7] A. Chokkalingam,et al. Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.
[8] E. Borden,et al. Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. , 2005, Biochemical and biophysical research communications.
[9] A. Haas,et al. Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. , 1987, The Journal of biological chemistry.
[10] C. Tangen,et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. , 2004, The New England journal of medicine.
[11] Steven Gygi,et al. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[12] P. Lengyel,et al. Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells , 1979, Nature.
[13] K. Loeb,et al. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. , 1992, The Journal of biological chemistry.
[14] B. Williams,et al. Functional classification of interferon‐stimulated genes identified using microarrays , 2001, Journal of leukocyte biology.
[15] I. Tannock,et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. , 2004, The New England journal of medicine.
[16] A W Partin,et al. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer. , 2001, The Journal of urology.
[17] E. Borden,et al. High-throughput Immunoblotting , 2003, The Journal of Biological Chemistry.